ISSN: 2572-4118

Breast Cancer: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective Article   
  • Breast Can Curr Res,
  • DOI: 10.4172/2592-4118.1000250

Immunotherapy?s Potential in Breast Cancer

Akira Terence*
Department of Biochemistry, Covenant University, Nigeria
*Corresponding Author : Akira Terence, Department of Biochemistry, Covenant University, Nigeria, Email: terenceakira1735@yahoo.com

Received Date: Apr 01, 2024 / Published Date: Apr 29, 2024

Abstract

Immunotherapy has emerged as a promising avenue for the treatment of breast cancer, offering new strategies to harness the body’s immune system against malignant cells. Recent advances in this field, including the development of immune checkpoint inhibitors and adoptive cell therapies, have shown promising results in certain subtypes of breast cancer. However, challenges such as variable treatment responses and immune-related adverse events remain. This article explores the recent progress in breast cancer immunotherapy and discusses future directions to optimize its efficacy and broaden its applicability.

Citation: Terence A (2024) Immunotherapy’s Potential in Breast Cancer. BreastCan Curr Res 9: 250. Doi: 10.4172/2592-4118.1000250

Copyright: © 2024 Terence A. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top